| Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial D Rubino, N Abrahamsson, M Davies, D Hesse, FL Greenway, C Jensen, ... Jama 325 (14), 1414-1425, 2021 | 566 | 2021 |
| Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: the SCALE insulin randomized controlled trial WT Garvey, AL Birkenfeld, D Dicker, G Mingrone, SD Pedersen, ... Diabetes care 43 (5), 1085-1093, 2020 | 122 | 2020 |
| Liraglutide 3.0 mg and intensive behavioral therapy (IBT) for obesity in primary care: the SCALE IBT randomized controlled trial TA Wadden, JS Tronieri, D Sugimoto, MT Lund, P Auerbach, C Jensen, ... Obesity 28 (3), 529-536, 2020 | 110 | 2020 |
| Effects of exercise and diet in nonobese asthma patients—a randomized controlled trial LL Toennesen, H Meteran, M Hostrup, NRW Geiker, CB Jensen, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (3), 803-811, 2018 | 86 | 2018 |
| Vitamin D intake in mid-pregnancy and child allergic disease–a prospective study in 44,825 Danish mother-child pairs E Maslova, S Hansen, CB Jensen, AL Thorne-Lyman, M Strøm, SF Olsen BMC pregnancy and childbirth 13, 1-14, 2013 | 79 | 2013 |
| Development and validation of a vitamin D status prediction model in Danish pregnant women: a study of the Danish National Birth Cohort C Bjørn Jensen, AL Thorne-Lyman, L Vadgård Hansen, M Strøm, ... PloS one 8 (1), e53059, 2013 | 73 | 2013 |
| COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months P Sivapalan, TS Ingebrigtsen, DB Rasmussen, R Sørensen, ... BMJ open respiratory research 6 (1), e000407, 2019 | 66 | 2019 |
| Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer … AK Waljee, PDR Higgins, CB Jensen, M Villumsen, SA Cohen-Mekelburg, ... The Lancet Gastroenterology & Hepatology 5 (3), 276-284, 2020 | 55 | 2020 |
| Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide … RC Ungaro, BN Limketkai, CB Jensen, KH Allin, M Agrawal, T Ullman, ... Gut 68 (6), 977-984, 2019 | 49 | 2019 |
| Sources and determinants of vitamin D intake in Danish pregnant women CB Jensen, SB Petersen, C Granström, E Maslova, C Mølgaard, SF Olsen Nutrients 4 (4), 259-272, 2012 | 48 | 2012 |
| Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study CB Jensen, LH Ängquist, MA Mendall, TIA Sørensen, JL Baker, T Jess Official journal of the American College of Gastroenterology| ACG 113 (5 …, 2018 | 43 | 2018 |
| Inflammatory bowel disease: experience of two Chilean centers CC Figueroa, PR Quera, EJ Valenzuela, BC Jensen Revista médica de Chile 133 (11), 1295-1304, 2005 | 37 | 2005 |
| The influence of early exposure to vitamin D for development of diseases later in life R Jacobsen, B Abrahamsen, M Bauerek, C Holst, CB Jensen, J Knop, ... BMC public health 13, 1-8, 2013 | 33 | 2013 |
| Elevated blood eosinophils in acute COPD exacerbations: better short-and long-term prognosis A Jabarkhil, M Moberg, J Janner, MN Petersen, CB Jensen, ... European Clinical Respiratory Journal 7 (1), 1757274, 2020 | 29 | 2020 |
| Predicted vitamin D status in mid‐pregnancy and child allergic disease E Maslova, S Hansen, AL Thorne‐Lyman, CB Jensen, M Strøm, A Cohen, ... Pediatric Allergy and Immunology 25 (7), 706-713, 2014 | 29 | 2014 |
| Socioeconomic inequalities in the incidence of alcohol-related liver disease: a nationwide Danish study G Askgaard, KM Fleming, C Crooks, F Kraglund, CB Jensen, J West, ... The Lancet Regional Health–Europe 8, 2021 | 28 | 2021 |
| Comparison of birth weight between school health records and medical birth records in Denmark: determinants of discrepancies CB Jensen, M Gamborg, B Heitmann, TIA Sørensen, JL Baker BMJ open 5 (11), e008628, 2015 | 24 | 2015 |
| Stopping mesalamine therapy in patients with Crohn’s disease starting biologic therapy does not increase risk of adverse outcomes RC Ungaro, BN Limketkai, CB Jensen, C Yzet, KH Allin, M Agrawal, ... Clinical Gastroenterology and Hepatology 18 (5), 1152-1160. e1, 2020 | 22 | 2020 |
| Secular trends in seasonal variation in birth weight CB Jensen, M Gamborg, K Raymond, J McGrath, TIA Sørensen, ... Early human development 91 (6), 361-365, 2015 | 22 | 2015 |
| STEP 4 Investigators. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized … D Rubino, N Abrahamsson, M Davies, D Hesse, FL Greenway, C Jensen JAMA 325 (14), 1414-1425, 2021 | 20 | 2021 |
